Felix Nikels Boehringer Ingelheim

Felix Nikels, Senior Principal Scientist in Global CMC Development at Boehringer Ingelheim’s Innovation Unit, drives scientific and technological progress in drug product analytics across biologics, peptides, small molecules, conjugates, and gene therapies. His work focuses on aggregation and particulate matter, bridging regulatory, analytical and biological implications with data‑driven strategies. A recognized leader, Felix champions cross‑functional collaboration and advanced methods that transform particle detection into actionable insight, elevating visual inspection and root‑cause investigations. Active in multi‑company consortia and expert networks, he helps shape industry standards. At the PDA Visual Inspection Forum 2026 in Dublin, Felix will share coniderations for meaningful risk assessment approaches for particlulate matter that help accelerate investigations and support regulatory filing.